2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sarcopenia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Motor Activity
1
Infections
1
Interventions
pembrolizumab
1281
Specimen Handling
927
Carboplatin
835
Magnetic Resonance Spectroscopy
834
Cyclophosphamide
809
Cisplatin
733
Nivolumab
683
Paclitaxel
638
Radiotherapy
614
Gemcitabine
582
Biopsy
558
Bevacizumab
482
Dexamethasone
446
fludarabine
411
Docetaxel
385
venetoclax
371
Oxaliplatin
368
Capecitabine
364
Fluorouracil
360
atezolizumab
346
durvalumab
340
Rituximab
334
Drug Therapy
332
Doxorubicin
319
Blood Specimen Collection
317
Radiosurgery
317
Standard of Care
311
Pemetrexed
307
Ipilimumab
306
Radiation
286
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Wearable Electronic Devices
×
1 year
×
Clear all
NCT07325305
2026-04-13
PROTECT
Murdoch Childrens Research Institute
Phase NA
Recruiting
60 enrolled
NCT07030998
2025-11-17
WEARABLES
Murdoch Childrens Research Institute
Recruiting
150 enrolled